23 November 2020 4 Min Read
AstraZeneca’s Covid-19 vaccine is effective, cheap and more easily transportable, it says
The UK drugmaker says it will have as many as 200-million doses by the end of 2020, about four times as many as US competitor Pfizer
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In